Astrana Health (ASTH) Competitors

Sezzle (NASDAQ:SEZL) and Astrana Health (NASDAQ:ASTH) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Which has more risk and volatility, SEZL or ASTH?

Sezzle has a beta of 9.17, suggesting that its stock price is 817% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.

Do analysts recommend SEZL or ASTH?

Sezzle currently has a consensus price target of $96.94, suggesting a potential downside of 42.15%. Astrana Health has a consensus price target of $53.29, suggesting a potential upside of 112.63%. Given Astrana Health's higher probable upside, analysts plainly believe Astrana Health is more favorable than Sezzle.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sezzle	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Astrana Health	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67

Do institutionals & insiders have more ownership in SEZL or ASTH?

2.0% of Sezzle shares are owned by institutional investors. Comparatively, 52.8% of Astrana Health shares are owned by institutional investors. 49.5% of Sezzle shares are owned by insiders. Comparatively, 8.5% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Does the media favor SEZL or ASTH?

In the previous week, Sezzle had 15 more articles in the media than Astrana Health. MarketBeat recorded 20 mentions for Sezzle and 5 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.57 beat Sezzle's score of 0.42 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sezzle	8 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Astrana Health	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable valuation & earnings, SEZL or ASTH?

Sezzle has higher earnings, but lower revenue than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Sezzle, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sezzle	$271.13M	20.58	$78.52M	$2.96	56.61
Astrana Health	$2.03B	0.69	$43.15M	$0.72	34.81

Is SEZL or ASTH more profitable?

Sezzle has a net margin of 32.42% compared to Astrana Health's net margin of 1.56%. Sezzle's return on equity of 114.37% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sezzle	32.42%	114.37%	35.02%
Astrana Health	1.56%	4.90%	2.68%

Summary

Sezzle beats Astrana Health on 12 of the 17 factors compared between the two stocks.